Gentian Diagnostics listed on the Oslo Stock Exchange

25. Jun 2021 | 2 min read

Gentian Diagnostics listed on the Oslo Stock Exchange

Gentian Diagnostics was today listed on the Oslo Stock Exchange

We made a promise to our shareholders when we were listed on Euronext Growth that we would aim for the main list when the company had matured. I’m pleased that we now have reached this milestone, and that we have access to a high-quality investor base as we work towards our ambitious targets of long-term growth and value creation. Through our diversified portfolio of tests, we provide a solid foundation for growth and value creation. To deliver on our ambition, we aim to bring one additional product to market per year and expand market access through achieving additional regulatory approvals and commercial partners.”

Hilja Ibert, CEO Gentian Diagnostics ASA

 

 

52118_Oslo-Børs_IPO_Gentian-Diagnostics_Video

 

About Gentian Diagnostics

Gentian’s portfolio of diagnostic tests contributes to early disease detection and faster availability of clinically relevant information, which lead to better treatment decisions. In addition, they contribute to improve laboratory productivity and cost-efficiency by leveraging PETIA technology, which enable 3-10x higher throughput than traditional immunoassay platforms. The tests target several large and growing disease areas such as infections and inflammation, kidney failure and congestive heart failure. Gentian has four established products, one product in market development, and two products in development with launches scheduled for Q4 2021 and Q1 2022, respectively. Gentian also has three undisclosed biomarkers in exploration and ‘proof of concept’ phases.

 

New call-to-action

 

 

You may also read


Available position: Sales and Application Specialist, Stockholm

Sep 14, 2021

Available position: Sales and Application Specialist, Stockholm

Sales and Application Specialist, Stockholm Gentian Diagnostics AB has an exciting opportunity to offer a..

Calprotectin as an early marker to prevent sepsis

Sep 13, 2021

Calprotectin as an early marker to prevent sepsis

Sepsis Awareness Month and World Sepsis Day September is sepsis awareness month, and the 10th World Sepsis..

Gentian at AACC 2021

Sep 09, 2021

Gentian at AACC 2021

Meet us at #2021AACC  Gentian looks forward to meeting you at the AACC 2021. For its fifth consecutive year,..